Home/Filings/4/0001225208-21-004053
4//SEC Filing

MACKENZIE ALEXANDER R 4

Accession 0001225208-21-004053

CIK 0000078003other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:05 PM ET

Size

11.4 KB

Accession

0001225208-21-004053

Insider Transaction Report

Form 4
Period: 2021-02-25
MACKENZIE ALEXANDER R
Executive Vice President
Transactions
  • Award

    Common Stock

    2021-02-25+26,732137,727 total
  • Tax Payment

    Common Stock

    2021-02-25$33.82/sh14,227$481,157123,500 total
  • Award

    Stock Appreciation Rights

    2021-02-25+84,27984,279 total
    Exercise: $33.82From: 2026-02-25Exp: 2026-02-25Common Stock (84,279 underlying)
  • Award

    Stock Appreciation Rights

    2021-02-25+72,82072,820 total
    Exercise: $33.82From: 2028-02-25Exp: 2028-02-25Common Stock (72,820 underlying)
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    10,106
Footnotes (4)
  • [F1]The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
  • [F3]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
  • [F4]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001678459

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:05 PM ET
Size
11.4 KB